Zhitong Finance App News, Kodi B (02487.HK) announced that the Group's CU-20101 (injectable type A botulinum toxin) biological product marketing license application (BLA) has been accepted by the China Drug Administration. The indication is to improve moderate to severe brow lines.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.